• Risks Digest 32.49 (3/3)

    From RISKS List Owner@21:1/5 to All on Fri Feb 12 23:21:58 2021
    [continued from previous message]

    returned.

    I make no comment on the wisdom or otherwise of any particular trading
    strategy or market regulation regime.

    ------------------------------

    Date: Sat, 6 Feb 2021 16:55:09 +0000
    From: Wols Lists <antlists@youngman.org.uk>
    Subject: Re: The calculus really is complex (Thorn, RISKS-32.48)

    But that promptly begs the question SHOULD we worry. And in my informed lay person's opinion the answer is a very big NO.

    We already know that immunity seems temporary. We already suspect that re-infection will be the norm (we haven't yet seen it much because the timescales are too short).

    And from what we know of Corona Viruses in general, CoVid does not appear
    that different.

    The big difference between Sars-Cov-2 and other corona viruses is that we've never met Sars-Cov-2 before. And it's the *first* *exposure* that seems to
    be the lethal one.

    Come next autumn, pretty much everyone will either (a) have been vaccinated,
    or (b) actually caught the virus. Or (c) be young who typically just shrug
    it off without even realising they've been infected.

    Which means, based on the experience of corona viruses and past pandemics, Sars-Cov-2 will become endemic in the background, mostly unrecognised, and might kill a few already weakened individuals every now and then.

    And mutations will simply sweep through the population with weakened
    immunity, who will for the most part fight it off maybe not even realising they've caught it, because it's basically the same virus even if it's
    changed slightly. Oh - and don't forget mutations on the whole tend to
    *weaken* a virus, not make it more lethal. It's not in the virus's interest
    to kill its host ...

    The real danger is Sars-Cov-3 popping up out of nowhere and subjecting us to
    a repeat of early 2020.

    ------------------------------

    Date: Mon, 1 Aug 2020 11:11:11 -0800
    From: RISKS-request@csl.sri.com
    Subject: Abridged info on RISKS (comp.risks)

    The ACM RISKS Forum is a MODERATED digest. Its Usenet manifestation is
    comp.risks, the feed for which is donated by panix.com as of June 2011.
    SUBSCRIPTIONS: The mailman Web interface can be used directly to
    subscribe and unsubscribe:
    http://mls.csl.sri.com/mailman/listinfo/risks

    SUBMISSIONS: to risks@CSL.sri.com with meaningful SUBJECT: line that
    includes the string `notsp'. Otherwise your message may not be read.
    *** This attention-string has never changed, but might if spammers use it.
    SPAM challenge-responses will not be honored. Instead, use an alternative
    address from which you never send mail where the address becomes public!
    The complete INFO file (submissions, default disclaimers, archive sites,
    copyright policy, etc.) is online.
    <http://www.CSL.sri.com/risksinfo.html>
    *** Contributors are assumed to have read the full info file for guidelines!

    OFFICIAL ARCHIVES: http://www.risks.org takes you to Lindsay Marshall's
    searchable html archive at newcastle:
    http://catless.ncl.ac.uk/Risks/VL.IS --> VoLume, ISsue.
    Also, ftp://ftp.sri.com/risks for the current volume/previous directories
    or ftp://ftp.sri.com/VL/risks-VL.IS for previous VoLume
    If none of those work for you, the most recent issue is always at
    http://www.csl.sri.com/users/risko/risks.txt, and index at /risks-32.00
    ALTERNATIVE ARCHIVES: http://seclists.org/risks/ (only since mid-2001)
    *** NOTE: If a cited URL fails, we do not try to update them. Try
    browsing on the keywords in the subject line or cited article leads.
    Apologies for what Office365 and SafeLinks may have done to URLs.
    Special Offer to Join ACM for readers of the ACM RISKS Forum:
    <http://www.acm.org/joinacm1>

    ------------------------------

    End of RISKS-FORUM Digest 32.49
    ************************

    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)